Target intelligence / Profile preview

Snake venom toxins from Crotalus basiliscus

Molecular classification
Enzyme, Toxin, Disintegrin, Peptide, Metalloproteinase, Phospholipase A2, Serine protease
01

Overview

The snake venom toxins from Crotalus basiliscus (Mexican west-coast rattlesnake) constitute a complex biochemical mixture primarily composed of enzymes and non-enzymatic proteins that facilitate prey capture and digestion (Wikipedia, NIH). The most abundant components are snake venom metalloproteinases (SVMPs), which account for approximately 68% of the venom and are the primary drivers of hemorrhage and local tissue necrosis (NIH, ResearchGate). Phospholipases A2 (PLA2s) make up about 14% and are the primary contributors to the venom's lethality through myotoxic and neurotoxic effects, often causing muscle necrosis and respiratory distress (NIH, UniProt). Other significant constituents include snake venom serine proteases (SVSPs), disintegrins like basilicin, and cysteine-rich secretory proteins (CRISPs) (UniProt, NIH). These toxins act synergistically to disrupt hemostasis, damage muscle tissue, and impair neuromuscular transmission (NIH). Clinical management of envenomation relies on polyvalent antivenoms, such as Antivipmyn or Anavip, which utilize purified antibodies to neutralize these toxins (NIH, Utah.edu). Additionally, specific toxins from this species are being investigated for their potential therapeutic utility in treating cardiovascular diseases and certain types of cancer (NIH).

Other names
Mexican west-coast rattlesnake venomCrotalus basiliscus venomMexican green rattler venom
02

Mechanism of action

Antivenoms contain antibodies or antibody fragments (Fab or F(ab')2) that bind to and neutralize the various toxic components of the venom, preventing their interaction with physiological targets such as the vascular endothelium, coagulation factors, and neuromuscular junctions (NIH, Utah.edu).

03

Biological functions

ProteolysisHemorrhageMyotoxicityNeurotoxicityPlatelet aggregation inhibitionHemostasis impairment
04

Disease associations

Snakebite envenomationHemorrhageMyonecrosisCoagulopathyNeurotoxicity
05

Safety considerations

AnaphylaxisSerum sicknessLocal tissue necrosisCompartment syndromeSecondary infection
06

Interacting drugs

Antivipmyn (Birmex antivenom)

4 more in the full profile.

07

Biomarkers

Creatine kinase (CK)Fibrinogen levelPlatelet countProthrombin time (PT)Partial thromboplastin time (PTT)

Beyond the preview

Go deeper on Snake venom toxins from Crotalus basiliscus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Snake venom toxins from Crotalus basiliscus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call